RT Journal Article
SR Electronic
T1 Tuberculosis: 13. Control of the disease among aboriginal people in Canada
JF Canadian Medical Association Journal
JO CMAJ
FD Canadian Medical Association
SP 351
OP 355
VO 162
IS 3
A1 FitzGerald, J. Mark
A1 Wang, Lei
A1 Elwood, R. Kevin
YR 2000
UL http://www.cmaj.ca/content/162/3/351.abstract
AB Case 1: A 36-year-old aboriginal woman has a 12-mm-diameter reaction to a tuberculosis (TB) skin test, done as part of a community survey. She was vaccinated with BCG (bacille Calmette-Guérin) at 6 weeks of age. There is no documented history of contact with TB, and no skin tests were carried out previously. The woman's family doctor wonders about the significance of the result. Case 2: A 27-year-old aboriginal man presents with a 6-week history of cough and fever and recent onset of hemoptysis. He has recently completed 2 courses of antibiotics, but there has been no improvement in symptoms. Chest radiography shows right upper lobe pneumonia. A further course of antibiotics is prescribed. What investigations should be completed next? Case 3: The mother of a 2-day-old aboriginal infant asks for advice about the benefits of BCG vaccination. She is confused about the side effects of BCG and its effectiveness.